All Stories

  1. Human enterotoxigenic Escherichia coli (ETEC) infections elicit antibodies that broadly neutralize mucinases of pathogenic Escherichia coli and ...
  2. EatA mediated degradation of intestinal mucus is species-specific and driven by MUC2 structural features
  3. ETEC heat-labile toxin promotes β-catenin stabilization and transcriptional reprogramming to disrupt intestinal epithelial differentiation
  4. Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  5. Degradation of the intestinal mucus layer by the ETEC protease EatA is species specific determined by the structure of the MUC2 mucin
  6. Parenteral Vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization
  7. Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin
  8. Host-derived CEACAM-laden vesicles engage enterotoxigenic Escherichia coli for elimination and toxin neutralization
  9. Structural and biophysical characterization of the secreted, β-helical adhesin EtpA of Enterotoxigenic Escherichia coli
  10. Interactions of pathogenic Escherichia coli with CEACAMs
  11. Spontaneous Bacterial Peritonitis Caused by Bordetella hinzii
  12. Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development
  13. Changing the locks on intestinal signaling
  14. Effect of chronic alcohol exposure on gut vitamin B7 uptake: involvement of epigenetic mechanisms and effect of alcohol metabolites
  15. Emerging Themes in the Molecular Pathogenesis of Enterotoxigenic Escherichia coli
  16. Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
  17. Acute Bacterial Gastroenteritis
  18. Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli
  19. The Intriguing Interaction of Escherichia coli with the Host Environment and Innovative Strategies To Interfere with Colonization: a Summary of the 2019 E. coli and the Mucosal Immune System Meeting
  20. CEACAMs serve as toxin-stimulated receptors for enterotoxigenic Escherichia coli
  21. Phosphodiesterase 5 (PDE5) restricts intracellular cGMP accumulation during enterotoxigenic Escherichia coli infection
  22. Mechanical Stimuli Affect Escherichia coli Heat-Stable Enterotoxin-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Model
  23. Comparative genomic analysis and molecular examination of the diversity of enterotoxigenic Escherichia coli isolates from Chile
  24. Mechanical Stimuli Affect E. Coli Heat Stable Enterotoxin (ST)-Cyclic GMP Signaling in a Human Enteroid Intestine-Chip Diarrhea Model
  25. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
  26. How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions
  27. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  28. Enterotoxigenic Escherichia coli Infections
  29. Molecular Determinants of Enterotoxigenic Escherichia coli Heat-Stable Toxin Secretion and Delivery
  30. Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity
  31. Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development
  32. Molecular determinants of enterotoxigenic Escherichia coli heat-stable toxin secretion and delivery
  33. A Role for Salivary Peptides in the Innate Defense Against Enterotoxigenic Escherichia coli
  34. Characterization of enterotoxigenic Escherichia coli strains isolated from the massive multi-pathogen gastroenteritis outbreak in the Antofagasta region following the Chilean earthquake, 2010
  35. Comparative genomics and transcriptomics of Escherichia coli isolates carrying virulence factors of both enteropathogenic and enterotoxigenic E. coli
  36. Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology
  37. Providing Structure to Enterotoxigenic Escherichia coli Vaccine Development
  38. Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions
  39. Dynamic Interactions of a Conserved Enterotoxigenic Escherichia coli Adhesin with Intestinal Mucins Govern Epithelium Engagement and Toxin Delivery
  40. Blood Group O–Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera
  41. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin
  42. Overcoming Enterotoxigenic Escherichia coli Pathogen Diversity: Translational Molecular Approaches to Inform Vaccine Design
  43. Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection
  44. Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli
  45. Contribution of the Highly Conserved EaeH Surface Protein to Enterotoxigenic Escherichia coli Pathogenesis
  46. Designing Vaccines to Neutralize Effective Toxin Delivery by Enterotoxigenic Escherichia coli
  47. Novel antigens for enterotoxigenicEscherichia colivaccines
  48. Enterotoxigenic Escherichia coli Secretes a Highly Conserved Mucin-Degrading Metalloprotease To Effectively Engage Intestinal Epithelial Cells
  49. EatA, an Immunogenic Protective Antigen of Enterotoxigenic Escherichia coli, Degrades Intestinal Mucin
  50. EnterotoxigenicEscherichia coli
  51. Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans
  52. Enterotoxigenic Escherichia coli
  53. Transcriptional Modulation of Enterotoxigenic Escherichia coli Virulence Genes in Response to Epithelial Cell Interactions
  54. Cooperative Role of Antibodies against Heat-Labile Toxin and the EtpA Adhesin in Preventing Toxin Delivery and Intestinal Colonization by Enterotoxigenic Escherichia coli
  55. Directed Evaluation of Enterotoxigenic Escherichia coli Autotransporter Proteins as Putative Vaccine Candidates
  56. Outer Membrane Vesicles Induce Immune Responses to Virulence Proteins and Protect against Colonization by Enterotoxigenic Escherichia coli
  57. Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by EnterotoxigenicEscherichia coli
  58. Infectious Agents of Food- and Water-Borne Illnesses
  59. Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins
  60. Lingual Leishmaniasis Complicating Visceral Disease
  61. Molecular mechanisms of enterotoxigenic Escherichia coli infection
  62. Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model
  63. Purification of recombinant high molecular weight two-partner secretion proteins from Escherichia coli
  64. Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells
  65. Heat-Labile Enterotoxin Promotes Escherichia coli Adherence to Intestinal Epithelial Cells
  66. The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection
  67. Directed delivery of heat-labile enterotoxin by enterotoxigenic Escherichia coli
  68. Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli
  69. Importance of Heat-Labile Enterotoxin in Colonization of the Adult Mouse Small Intestine by Human Enterotoxigenic Escherichia coli Strains
  70. Identification and Molecular Characterization of EatA, an Autotransporter Protein of Enterotoxigenic Escherichia coli
  71. Interaction of an Outer Membrane Protein of Enterotoxigenic Escherichia coli with Cell Surface Heparan Sulfate Proteoglycans
  72. Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens
  73. Identification of a Gene within a Pathogenicity Island of Enterotoxigenic Escherichia coli H10407 Required for Maximal Secretion of the Heat-Labile Enterotoxin
  74. Incidental Discovery of Emphysematous Cystitis
  75. Cryptococcal Skull Infection